In Ovo raised €34M in a Series B round in Mar 2022. The company is based in Leiden, Netherlands. Investors in the round: ABN AMRO, Demcon, European Circular Bioeconomy Fund (ECBF) and 3 others. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €34M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
